| Business Summary | | SeraCare,
Inc.
conducts
business
through
two
segments:
the
Therapeutics
Products
Segment,
which
consists
primarily
of
the
plasma
collection
operations,
and
the
Diagnostics
Products
Segment,
which
encompasses
the
manufacturing
and
sale
of
various
products
for
diagnostic
applications.
The
Company's
plasma
collection
operation
has
become
a
significant
factor
in
the
business
of
collecting
and
selling
source
plasma
to
manufacturers
of
pharmaceutical
and
diagnostic
products
(called
fractionators).
While
the
primary
product
of
the
Company's
Therapeutics
segment
continues
to
be
source
plasma,
it
also
collected
and
sold
Cytomegalovirus
Antibody
Plasma,
Tetanus
Antibody
Plasma,
HbSag
(hepatitus
positive)
plasma
and
various
other
antibody
positive
and
negative
plasma. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SeraCare,
Inc.
is
a
fully
integrated
collector,
manufacturer
and
marketer
of
plasma
based
diagnostic
products
and
tests,
and
is
engaged
in
the
collecting
and
selling
of
source
and
hyperimmune
plasma.
For
the
three
months
ended
5/31/01,
total
revenue
rose
43%
to
$18.4
million.
Net
income
applicable
to
Common
totaled
$683
thousand,
up
from
$229
thousand.
Results
reflect
increased
shipments
to
the
Company's
primary
customer
and
improved
operating
margins. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Barry Plost, 54 Chairman,
Pres, CEO, Director | $312K | Jerry Burdick, 60 Exec.
VP, CFO, Sec., Director | 175K | Dollar amounts are as of 29-Feb-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|